Literature DB >> 24139476

Persistence of measles neutralizing antibody related to vaccine and natural infection acquired before HIV infection.

M B Isa1, J V Pavan1, P Sicilia Don1, S Grutadauria2, L C Martinez1, M O Giordano1, G Masachessi1, P A Barril1, S V Nates1.   

Abstract

Little is known about long-lasting measles protective immunity when exposure to wild-type or vaccine measles virus precedes HIV infection. The results obtained suggest that measles immunity wanes and the lowest measles geometric mean titres (GMT) were significantly associated with measles vaccine-induced immunity in individuals that later developed HIV infection (86% prevalence, GMT 164 mIU/ml) compared to naturally induced immunity in HIV-infected adults (100% prevalence, GMT 340 mIU/ml, P = 0·0082) or non-HIV infected adults (100%, GMT 724 mIU/ml, P = 0·0001), and vaccine-induced immunity in non-HIV-infected adults (100%, GMT 347 mIU/ml, P = 0·017). The study was conducted in an area without wild-type virus circulation since 2000. The absence of virus circulating may alter the paradigm of lifelong immunity to measles virus after vaccination. As the proportion of HIV-infected individuals possessing only vaccine-induced immunity continues to grow, checking the status of measles immunity in this group is strongly recommended.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24139476      PMCID: PMC9151213          DOI: 10.1017/S0950268813002628

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  11 in total

1.  Progress toward elimination of rubella and congenital rubella syndrome--the Americas, 2003-2008.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-10-31       Impact factor: 17.586

2.  Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection.

Authors:  Kehmia Titanji; Angelo De Milito; Alberto Cagigi; Rigmor Thorstensson; Sven Grützmeier; Ann Atlas; Bo Hejdeman; Frank P Kroon; Lucia Lopalco; Anna Nilsson; Francesca Chiodi
Journal:  Blood       Date:  2006-04-27       Impact factor: 22.113

3.  Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection.

Authors:  Joseph J Mattapallil; Daniel C Douek; Brenna Hill; Yoshiaki Nishimura; Malcolm Martin; Mario Roederer
Journal:  Nature       Date:  2005-04-28       Impact factor: 49.962

4.  Measles seroprevalence and vaccine response in HIV-infected adults.

Authors:  M R Wallace; D G Hooper; S J Graves; J L Malone
Journal:  Vaccine       Date:  1994-10       Impact factor: 3.641

Review 5.  Measles.

Authors:  William J Moss; Diane E Griffin
Journal:  Lancet       Date:  2011-08-17       Impact factor: 79.321

Review 6.  B lymphocyte dysfunctions in HIV infection.

Authors:  Angelo De Milito
Journal:  Curr HIV Res       Date:  2004-01       Impact factor: 1.581

7.  The prevalence of measles antibody in human immunodeficiency virus-infected patients in northern California.

Authors:  C A Kemper; M Gangar; G Arias; C Kane; S C Deresinski
Journal:  J Infect Dis       Date:  1998-10       Impact factor: 5.226

8.  Neutralization enzyme-linked immunosorbent assay for evaluation of immunity to measles virus.

Authors:  S V Nates; G Y Rey; M O Giordano; A R Depetris; J Boshell
Journal:  Viral Immunol       Date:  1995       Impact factor: 2.257

9.  Expansion of HIV-specific T follicular helper cells in chronic HIV infection.

Authors:  Madelene Lindqvist; Jan van Lunzen; Damien Z Soghoian; Bjorn D Kuhl; Srinika Ranasinghe; Gregory Kranias; Michael D Flanders; Samuel Cutler; Naomi Yudanin; Matthias I Muller; Isaiah Davis; Donna Farber; Philip Hartjen; Friedrich Haag; Galit Alter; Julian Schulze zur Wiesch; Hendrik Streeck
Journal:  J Clin Invest       Date:  2012-08-27       Impact factor: 14.808

Review 10.  B cells in HIV infection and disease.

Authors:  Susan Moir; Anthony S Fauci
Journal:  Nat Rev Immunol       Date:  2009-04       Impact factor: 53.106

View more
  2 in total

1.  Reiteration of the elimination status of measles in the southeast of Iran, 2015.

Authors:  Shahrokh Izadi; Masoome Arabsalmani; Mahdi Mohammadi; Seyed Mehdi Tabatabaei; Ali-Akbar Haghdoost
Journal:  Hum Vaccin Immunother       Date:  2018-09-05       Impact factor: 3.452

2.  Increased Hepatitis E Virus Seroprevalence Correlates with Lower CD4+ Cell Counts in HIV-Infected Persons in Argentina.

Authors:  José D Debes; Maribel Martínez Wassaf; María Belén Pisano; María Beatriz Isa; Martin Lotto; Leonardo G Marianelli; Natalia Frassone; Estefania Ballari; Paul R Bohjanen; Bettina E Hansen; Viviana Ré
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.